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Abstract
Background: Persistent infection with high-risk human papillomavirus (HR-HPV) is the most important risk factor for
the development of cervical cancer, but factors contributing to HR-HPV persistence are incompletely understood.
The objective of this study was to test for associations of chronic stress and two aspects of diurnal cortisol secretion
(i.e., the cortisol awakening response [CAR] and total cortisol output over the day [AUCgday]) with HR-HPV status at
baseline and 12 months later (follow-up).
Methods: We evaluated 188 women (25 ± 3 years) at baseline. Follow-up investigation was restricted to HR-HPV
infected women at baseline. Of the initial 48 HR-HPV positive participants, 42 completed the follow-up (16 HR-HPV
positive and 26 HR-HPV negative). At baseline and follow-up, we determined HR-HPV status in cervical smears,
assessed chronic stress, and repeatedly measured salivary cortisol over the day. At baseline, we analyzed salivary
cortisol only in a subgroup of 90 participants (45 HR-HPV negative and 45 HR-HPV positive).
Results: At baseline, higher chronic stress (excessive demands at work: p = .022, chronic worrying: p = .032), and a
higher CAR (p = .014) were related to baseline HR-HPV positivity. At follow-up, there was a statistical trend for a
positive association between the CAR and HR-HPV positivity (p = .062). Neither the CAR nor the AUCgday mediated
the associations between chronic stress and HR-HPV status.
Conclusions: Our findings suggest that both chronic stress and diurnal cortisol are related to the presence of HR-
HPV infection and may thus play a role in HPV-associated cervical carcinogenesis.
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Background
Cervical cancer is the fourth most common cancer in
women worldwide, with an estimated incidence of 500,
000 cases per year [1, 2]. The most important risk factor
for the development of cervical cancer is high-risk
human papillomavirus (HR-HPV) infection of cervical
mucosa cells [3]. More than 60% of HR-HPV infections
are cleared within 6–12months and cause no pathological
changes, but in some women infections persist and can
progress to cervical intraepithelial neoplasia (CIN) and
cervical cancer [4, 5]. Although the factors and precise
mechanisms regulating the course of HR-HPV infection
are not completely understood, clinical and epidemio-
logical data revealed an association between HR-HPV
clearance and effector functions of T lymphocytes, also
referred to as cell-mediated immunity (CMI) [6, 7].
Animal and human studies provide converging evi-
dence that chronic stress compromises CMI, particularly
cytotoxic T lymphocyte (CTL) and CD4+ T cell activity,
CD4+ T cell and CTL counts, and lymphocyte migration
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and proliferation [8–15]. There is evidence that the
stress effects on the immune system are mediated by
glucocorticoids (GCs) [9, 16, 17], which are released
from the adrenal cortex into plasma as the end product
of the hypothalamus-pituitary-adrenal (HPA) axis in re-
sponse to stress and thus in characteristic stress-related
patterns [18]. A large body of literature indicates
prolonged hypersecretion of GCs and heightened GC
secretion occurring during the first hour after awakening
(cortisol awakening response, CAR) under chronic job
and general life stress conditions [19, 20]. Increased GC
levels in turn have been shown in vitro and ex vivo to
compromise the equilibrium between type 1 T-helper
(Th1) cell and Th2 cell activity by differential modula-
tion of cytokine expression, resulting in a shift from a
Th1 to a Th2 response [21]. Notably, whereas Th1 cell
activity contributes to CMI, Th2 cell activity favors the
humoral immune response [22–24]. Hence, increased
stress-induced GC levels are presumed to systematically
suppress Th1-mediated CMI, while causing a shift to-
ward Th2-mediated humoral immunity.
Considering the suppressive effects of chronic
stress and increased GC levels on CMI, and given
the importance of cell-mediated immune responses
in HR-HPV clearance, chronic psychological stress
may participate in promoting HR-HPV persistence
and thus HPV-associated cervical cancer progression
mediated by cortisol. Indeed, several studies have
demonstrated associations between psychosocial
stress and prevalence and progression of HPV-
associated cervical dysplasia and cancer [25–31],
although not unequivocally so [32, 33]. Among the
hitherto published studies, however, most used cross
sectional or retrospective designs and focused on the
association between stress and cervical dysplasia or
cancer; only two studies were of prospective nature
[31, 32] and only one directly focused on the associ-
ation between chronic stress (i.e., bereavement) and
HR-HPV infection [25].
Concerning mechanisms that might underlie the
possible link between psychosocial stress and HR-HPV
persistence, a case-control study in Caucasian women
provided first evidence for stress-related decrements in
proliferative T-cell responses to HPV-16 suggesting
suppressed cell-mediated immune responses as mediator
[34]. However, to the best of our knowledge, no study
has previously examined associations between cortisol
and HR-HPV presence or persistence as an additional
psycho-endocrine mechanism linking stress and HPV-
mediated cervical neoplasia and cancer.
Therefore, the purpose of this study was to test for
associations of chronic stress and two aspects of diurnal
cortisol secretion (i.e., the cortisol awakening response
and total cortisol output over the day), with HR-HPV
presence and persistence. We measured chronic stress,
salivary cortisol, and HR-HPV status at baseline and 12-
months after baseline. Our main hypotheses were that a)
higher levels of chronic stress, a higher cortisol awaken-
ing response, and a higher total cortisol output would be
associated with an increased risk of HR-HPV positivity
at baseline (i.e., HR-HPV presence) and 12months after
baseline (i.e., HR-HPV persistence) and that b) the
hypothesized association between chronic stress and
HR-HPV presence/persistence would be statistically
mediated by a higher cortisol awakening response and
by a higher total cortisol output.
Methods
Participants
This study was part of a large research project, in which
a random sample of 188 young women was recruited by
aid of collaborating physicians and advertisements.
Participants with any self-reported acute or chronic
immune-related disease (e.g., autoimmune disorder,
HIV-positive status, current infectious diseases) were
not eligible for the study. Explicit exclusion criteria, ob-
tained by participants’ self-report, were: age < 18 or > 31
years, virginity, HPV vaccination, pregnancy in the past
or currently pregnant, irregular gynecological check-ups
(i.e., more than 2 years in between visits, representing
the standard in Switzerland), HPV diagnosis at last
gynecological check-up, treatment of cervical abnormal-
ities during the last year, and previous cervical conization.
Of the total of 1477 participants assessed for study
eligibility, 188 participants were enrolled (see Fig. 1 for
details on participant flow). Of these, 48 participants
were tested HR-HPV positive and 140 HPV negative.
Based on a power analysis (see statistical analysis) and
for reasons of limited funding, we analyzed salivary
cortisol in 90 participants (i.e., 45 HR-HPV negative
[cortisol-control group] and 45 HR-HPV positive).
Notably, three participants of the HR-HPV positive
group had to be excluded because of non-adherence to
sampling time (see study procedure). The allocation of
HR-HPV negative participants to the ‘cortisol-control
group’ (n = 45) was randomly achieved by using 140
opaque and sealed envelopes for all of our 140 HR-HPV
negative participants, i.e., one envelope for each HR-
HPV negative participant. An independent research
assistant generated the random allocation sequence by
sealing, mixing, and subsequently opening 45 opaque
envelopes. Due to technical problems with assaying, data
of cortisol were missing in 4 participants rendering a
final sample of 41 HR-HPV negative women and 45 HR-
HPV positive women for cortisol measurements.
Follow-up investigation was restricted to women with
HR-HPV infection at baseline. Of the initial 48 HR-HPV
positive participants, 42 (87.5%) completed the 12-month
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follow-up. Of these, 16 participants (38%) were still HR-
HPV positive while 26 participants (62%) were negative to
HR-HPV.
Procedures
All participants who passed the screening were given
detailed written information about the study purpose
and procedure. Two weeks before their next routine
check-up with their gynecologist, the participants
received a link for a baseline online questionnaire (T1),
which included questions addressing demographics,
chronic stress, and suspected covariates (see self-
reported measures for more information). The question-
naire had to be filled in before the routine gynecological
check-up. In addition, participants received material
(DNAPap™ Cervical Sampler; Qiagen Gaithersburg, Inc.,
USA) and written instructions for HPV testing by means
of a cervical swab, which was to take place during the
routine check-up at their gynecologist’s practice. In de-
tail, participants were asked not to schedule their routine
gynecological check-up during menstruation, to abstain
from vaginal cream, spermicides, and lubricants three
days before the examination, and to abstain from sexual
intercourse two days before the examination. Cervical
samples were collected by healthcare professionals during
the routine gynecological check-up. After cervical cells
were collected via the DNAPap™ Cervical Sampler, the
system was sent to a specialized laboratory for HPV test-
ing (Laboratory Enders & Partners; Stuttgart, Germany).
Moreover, participants received material and written
instructions for saliva collection to assess the diurnal
cortisol secretion using Salivette collection devices
(Sarstedt, Sevelen, Switzerland). All participants were
instructed to collect 7 saliva samples over the course of
a regular workday within two weeks after HPV testing.
For cortisol awakening response assessment, saliva
samples were collected immediately after awakening
(while still lying in bed), 30, and 60min thereafter. To
assess the cortisol output over the day, samples were
collected at 11:00, 14:00, 17:00, and 20:00 h. Participants
were asked to abstain from strenuous physical activity
and from alcohol consumption 24 h before saliva collec-
tion. In addition, participants were asked to abstain from
smoking starting on the morning of saliva collection as
well as from brushing their teeth, eating and drinking
for 20 min prior to sample collection. To control the
sampling time self-reports of the exact sampling time
were used. Three participants of the HR-HPV positive
group had to be excluded from the analysis due to
sampling time. Saliva samples were stored in a fridge
until sampling was completed and were then sent to the
biochemical laboratory at the Institute of Psychology of
the University of Zurich, Switzerland, and stored at − 20
C until biochemical analysis.
Follow-up investigation was restricted to women with
HR-HPV infection at baseline. For follow-up 12months
after baseline (T2), participants with HR-HPV positive
status at baseline were contacted again 1 month before
Fig. 1 Participant flow throughout the study
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T2. Notably, we chose a follow-up of 12 months because
the risk of CIN grade 2 or worse diagnosis by 30months
has been found to be over 50% among women younger
than 30 years with HR-HPV infections that persisted at
least 12 months [4]. Study procedure as well as psycho-
metric and biochemical measures were analogous to T1.
In brief: Participants had to fill in an online question-
naire within a period of 2 weeks before a cervical swab.
In addition, they were instructed to collect 7 saliva
samples over the course of a regular workday within a
period of two weeks after cervical swab.
The Ethics Committee of the University of Zurich,
Switzerland, formally approved the research protocol,
which was conducted in accordance with the principles
of the Declaration of Helsinki. All participants provided
written informed consent before participating in the
study and were compensated with 120 CHF for their
participation.
Biological measures
Assessment of HPV status
Cervical swab cells collected with the DNAPap™ Cervical
Sampler were tested for HR-HPV infections at the
laboratory Enders & Partners (Stuttgart, Germany) using
the hc2 High-Risk HPV DNA Test® from QIAGEN
(Gaithersburg, Inc., USA). The hc2 is an in vitro nucleic
acid hybridization assay with signal amplifications using
microplate chemiluminescence for the qualitative detec-
tion of DNA in cervical specimens of 13 of the most fre-
quently found HR-HPV types in cervical tumors [35],
i.e., HR-HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59,
68. The assay was performed with cutoff of 1.0 pg/ml
recommended by Food and Drug Administration (FDA).
Cortisol analysis
At baseline, we analyzed salivary cortisol only in a
subgroup of 90 participants (i.e., 45 HR-HPV negative
and 45 HR-HPV positive) due to reasons of limited
funding (see section study participants). Thawed saliva
samples were centrifuged at 2000 g for 10 min, yielding
low-viscosity saliva. Salivary free cortisol concentrations
were determined using a commercial chemilumines-
cence immunoassay with high sensitivity of 0.16 ng/ml
(LIA, IBL Hamburg, Germany). Inter- and intra-assay
variation was below 11.5 and 7.7%, respectively. All sam-
ples of one subject were analyzed in the same run.
Psychological measures
Chronic stress
We assessed the amount of chronic stress over the last
3 months both at baseline and follow-up and by means
of the Trier Inventory for the Assessment of Chronic
Stress (TICS) [36]. The TICS is a 57-item questionnaire
measuring 9 interrelated factors of chronic stress in
addition to a screening scale for chronic stress (SSCS):
1) Work Overload, 2) Social Overload, 3) Pressure to
Perform, 4) Work Discontent, 5) Excessive Demands at
Work, 6) Lack of Social Recognition, 7) Social Tensions,
8) Social Isolation, and 9) Chronic Worrying. Using a 5-
point rating scale ranging from 0 (never) to 4 (very
often), participants were asked to rate how often they
have had a certain experience or have experienced a
certain situation within the last three months. Higher
scores mean higher extent of chronic stress. Cronbach’s
alpha was .87 in our sample for the SSCS indicating
good reliability.
Control variables
We assessed contraceptive use, age at onset of sexual
intercourse, total number of sexual partners, and
smoking status and intensity based on previous findings
suggesting associations with risk of genital HPV infec-
tion [37]. Smoking intensity was assessed by the average
number of monthly smoked cigarettes. The total number
of sexual partners was assessed by asking the partici-
pants how many sexual partners they have had in the
past. Hormonal contraceptives were binary coded as
using hormonal contraceptives vs. not using contracep-
tives. Moreover, we assessed sleep quality using the
Pittsburgh Sleep Quality Index (PSQI) [38] due to its po-
tential effects on cortisol responses [39, 40].
Statistical analyses
Data were analyzed using SPSS Inc. version 23.0 for Mac
OS X (Chicago, IL, USA) and presented as mean ± SEM.
G*Power 3.1 defined an optimal sample size of n = 90 to
detect a medium effect size of f = .30 in general linear
models given two groups and the cortisol awakening
response (CAR) or the daily area under the curve with
respect to the ground (AUCgday [41]), respectively, as
dependent variable with a power of 0.80. All tests were
two-tailed with the significance level set at p ≤ .05 and
the level of a statistical trend set at p ≤ .10. Data were
tested for normal distribution using a Kolmogorov–
Smirnov test before further statistical procedures were
applied. We applied Huynh-Feldt correction for repeated
measures. The CAR was calculated as the difference
between the peak cortisol response (i.e., 30 min after
awakening) minus cortisol level at awakening [42]. To
evaluate total cortisol output over the study period, the
AUCgday was calculated integrating the respective 0
min, 30 min, and 60 min after awakening, 11:00, 14:00,
17:00, and 20:00 cortisol sample. Body mass index (BMI)
was calculated as the ratio of weight in kilograms to
height in square meters. Across the study groups univar-
iate analyses of variance (ANOVAs) were calculated to
test for differences in group characteristics and chronic
stress. To test for associations between chronic stress
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and HR-HPV status, logistic regression analyses were
performed. To predict HR-HPV status at T1 or T2, we
entered in a first step (model 1) potential HR-HPV risk
factors (covariates) and in a second step (model 2) the
chronic stress factor.
To examine the associations between cortisol and HR-
HPV status, repeated measures ANCOVAs were applied
with HR-HPV status as the group variable and the 3
(CAR) or 7 (AUCgday) time points at which cortisol was
measured as repeated measures. To additionally test for
group differences in the CAR and in the AUCgday, and
single cortisol time points, we performed univariate
ANCOVAs. To examine whether the cortisol measures
(CAR, AUCgday) were mediators of the hypothesized
associations between chronic stress and HR-HPV status,
we performed mediator analyses using the PROCESS
macro [43]. In the proposed mediation model chronic
stress was tested as predictor and the HR-HPV status as
outcome with the cortisol measures (i.e., CAR, AUCg-
day) as mediators. Statistical mediation of an association
between predictor and outcome holds if the predictor is
significantly associated with the mediator, and the
mediator is significantly associated with the outcome
while controlling for the predictor [44]. By default, the
PROCESS macro uses a bootstrapping approach with
1000 bootstrap resamples and a 95% confidence interval
of the indirect effects, which were adopted in this study.
In terms of covariates, we controlled a priori for the
potential HPV risk factors contraceptive use, age at on-
set of sexual intercourse, number of sexual contacts, and
smoking intensity [37] in all statistical analyses involving
HR-HPV status at baseline and follow-up. Additionally,
we have taken sleep quality into account as covariate in
all statistical analyses involving cortisol measures. Effect
size parameters (f) were calculated from partial η2-values
and are reported where appropriate (effect size conven-
tions: f: .10 = small, .25 =medium, .40 = large).
Results
Participant characteristics
Table 1 (left) provides the characteristics of participants
per HR-HPV status at T1 (baseline). The HR-HPV
positive group (n = 48) had more sexual partners during
their lifetime and included more smokers than the HR-
Table 1 Participants’ characteristics per HR-HPV status at baseline and at follow-up
HR-HPV at baseline P-value HR-HPV at follow-up P-value
No (n = 140;
control group; 1)
No (n = 41;
cortisol-control
group; 2)
Yes (n = 48; 3) 1 vs. 3 2 vs. 3 No (n = 26) Yes (n = 16)
Age (years), M ± SEM 24.9 ± .26 23.8 ± .44 25.1 ± .44 .63 .043 26.4 ± .62 26.2 ± .71 .81
BMI (kg/m2), M ± SEM 21.8 ± .25 21.2 ± .37 21.6 ± .51 .73 .55 21.6 ± .63 21.0 ± .51 .50
Employment, n (%) .77 .25 .17
Yes 105 (75%) 27 (65.9%) 37 (77.1%) 23 (88.5%) 16 (100%)
No 35 (25%) 14 (34.1%) 11 (22.9%) 3 (11.5%) 0
Hormonal contraceptive
use, n (%)
87 (62.2%) 26 (63%) 32 (67%) .58 .75 17 (65%) 10 (62%) .85
Age at onset of sexual
intercourse,
M ± SEM
17.1 ± .17 17.2 ± .33 16.6 ± .27 .13 .15 16.3 ± .35 16.8 ± .46 .42
Marital status, n (%) .86 .90 .063
Single 38 (27.1%) 7 (17.1%) 18 (37.5%) 8 (30.8%) 2 (12.5%)
Relationship 95 (67.9%) 34 (82.9%) 26 (54.2%) 18 (69.2%) 12 (75%)
Married 7 (5%) 0 3 (6.2%) 0 2 (12.5%)




7.1 ± 7.4 5.5 ± 5.6 10.8 ± 8.4 .005 .001 13.9 ± 13.1 8.9 ± 6.0 .16
Smoker, n (%) 43 (30.7%) 15 (36.6%) 25 (52.1%) .008 .143 17 (65.4%) 5 (31.3%) .075
Cigarettes per month,
M ± SEM
106.4 ± 152.7 64.7 ± 116.2 128.1 ± 111.5 .54 .095 128.8 ± 125.1 99.2 ± 77.6 .63
Sleep quality (PSQI),
M ± SEM
9.55 ± 1.93 9.39 ± 2.21 9.96 ± 2.13 .23 .23 4.77 ± 2.77 4.25 ± 1.69 .50
Notes. BMI body mass index, PSQI Pittsburgh Sleep Quality Index, global PSQI score (min. Score: 0, max. Score: 21)
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HPV negative control group (n = 140). No significant
group differences were found in terms of age, BMI, em-
ployment, marital status, use of hormonal contracep-
tives, age at onset of sexual intercourse, sleep quality
and numbers of cigarettes smoked per month. When
comparing the HR-HPV positive group with the HR-
HPV negative cortisol-control group (n = 41) the results
did not significantly change, with the exception of age
and numbers of cigarettes smoked per month. The HR-
HPV positive group was older and engaged in heavier
cigarette smoking when compared to the HR-HPV nega-
tive cortisol-control group. At T2 (follow-up), the HR-
HPV positive group (n = 16) included less smokers and
single women than the HR-HPV negative group (n = 26).
No group differences were found in terms of age, BMI,
employment, use of hormonal contraceptives, age at on-
set of sexual intercourse, number of cigarettes smoked
per month, and sleep quality; see Table 1 [right]). See
Table 2 for participants’ psychological characteristics per
HR-HPV status at T1 and T2.
Associations between chronic stress and HR-HPV status
We calculated logistic regression analyses to address
whether chronic stress was associated with the likelihood
of being HR-HPV positive at T1 and T2. At baseline,
higher levels of excessive demands at work were signifi-
cantly related to HR-HPV positivity (b = .143, p = .022,
OR = 1.15, 95% CI: 1.02–1.30), independent of contra-
ceptive use, age at onset of sexual intercourse, number
of sexual contacts, and smoking intensity. Moreover,
higher levels of chronic worrying (b = .152, p = .032,
OR = 1.16, 95% CI: 1.01–1.34) at T1 were related to HR-
HPV positivity at T1, independent of contraceptive use,
age at onset of sexual intercourse, number of sexual con-
tacts, and smoking intensity. At follow-up, chronic stress
levels remained the same (except for a slight increase in
lack of social recognition, p = .025), but no significant as-
sociations with the likelihood of being HR-HPV positive
emerged.
Associations between cortisol and HR-HPV status
At baseline, the study groups significantly differed in
post-awakening cortisol levels (interaction group-by-
time: F (1.9/ 144.1) = 3.53, p = .035, f = 0.21; see Fig. 2a),
independent of contraceptive use, age at onset of sexual
intercourse, number of sexual contacts, smoking inten-
sity, and sleep quality. Post hoc tests revealed no signifi-
cant group differences in cortisol levels at awakening,
but a significantly higher cortisol peak response to awak-
ening in the HR-HPV positive group compared to the
HR-HPV negative group (F (1/77) = 6.31, p = .014, f =
0.29). The groups also significantly differed in cortisol
output over the day (interaction group-by-time: F (3.0/
233.7) = 3.41, p = .018, f = 0.21), with a higher (inte-
grated) overall cortisol secretion in the HR-HPV positive
group as compared to the HR-HPV negative group by
trend (AUCgday: F (1/77) = 3.714, p = .058, f = 0.22).
At follow-up, the study groups significantly differed in
post-awakening cortisol levels (interaction group-by-
time: F (2/70) = 3.93, p = .024, f = 0.34; see Fig. 2b), inde-
pendent of contraceptive use, age at onset of sexual
intercourse, number of sexual contacts, smoking inten-
sity, and sleep quality. Post hoc tests revealed no signifi-
cant group differences in cortisol level at awakening.
However, on a trend level, the HR-HPV positive group
Table 2 Participants’ psychological characteristics per HR-HPV status at baseline and at follow-up given as means and standard
errors
HR-HPV at baseline (T1) P-value HR-HPV at follow-up (T2) P-value
No (n = 140;
control group)
No (n = 41;
cortisol-control
group)
Yes (n = 48) 1 vs. 3 2 vs. 3 No (n = 26) Yes (n = 16)
TICS
Work overload 21.4 ± 0.50 21.2 ± 1.08 22.5 ± 0.94 .30 .37 23.4 ± 1.56 23.9 ± 1.82 .82
Social overload 14.1 ± 0.36 13.0 ± 0.68 14.1 ± 4.9 .99 .30 16.1 ± 1.06 15.8 ± 1.08 .84
Pressure to perform 24.6 ± 0.46 23.0 ± 0.86 24.1 ± 0.82 .59 .34 26.2 ± 1.07 24.4 ± 1.32 .32
Work discontent 18.2 ± 0.42 17.3 ± 0.80 19.1 ± 0.75 .29 .11 19.0 ± 1.00 19.4 ± 1.01 .78
Excessive demands at work 11.8 ± 0.28 10.9 ± 0.55 13.1 ± 0.66 .044 .017 12.7 ± 0.88 12.2 ± 1.05 .74
Lack of social recognition 8.7 ± 0.30 8.1 ± 0.5 8.4 ± 0.41 .53 .67 9.1 ± 0.62 9.3 ± 0.63 .83
Social tensions 11.4 ± 0.30 10.8 ± 0.48 10.7 ± 0.48 .29 .97 11.3 ± 0.74 13.1 ± 1.12 .18
Social isolation 12.7 ± 0.40 12.0 ± 0.82 13.1 ± 0.72 .68 .35 12.6 ± 1.00 13.3 ± 1.42 .69
Chronic worrying 10.7 ± 0.28 9.7 ± 0.57 11.4 ± 0.57 .29 .042 10.7 ± 0.82 12.3 ± 1.10 .25
Screening scale (SSCS) 28.8 ± 0.59 26.8 ± 1.35 30.3 ± 1.26 .21 .061 30.2 ± 1.99 32.1 ± 2.17 .54
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showed a higher cortisol peak response to awakening
than the HR-HPV negative group (F (1/35) = 3.71), p =
.062, f = 0.33). The cortisol output over the day did not
differ significantly between the HR-HPV positive group
and the HR-HPV negative group (interaction effect
group-by-time: p = .09; AUCgday: p = .50).
Mediation of stress chronic stress effects on HR-HPV
status by cortisol
Neither the CAR nor the AUCgday were found to
mediate the associations between chronic stress (i.e.,
excessive demands at work and chronic worrying) and
HR-HPV status at T1.
Fig. 2 a & b Cortisol awakening response and cortisol output over the day in women with and without HR-HPV given as means and standard
errors. AA, after awakening. a: At baseline. b: At follow-up
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Discussion
To the best of our knowledge, this is the first study that
investigated the effects of chronic stress and different as-
pects of diurnal cortisol secretion on HR-HPV presence
and persistence in young women.
As hypothesized, we found higher chronic stress levels,
as measured by the TICS subscales excessive demands at
work and chronic worrying to be associated with
increased likelihood of HR-HPV positivity at baseline.
These results were independent of potential HPV infec-
tion risk factors that were assessed at each measurement
time point, including number of sexual contacts, age at
onset of sexual intercourse, smoking intensity, and
contraceptive use.
Our results provide first indications that chronic stress
is an independent risk factor for HR-HPV presence in
young women. This finding is in line with the hitherto
single published human study that investigated associa-
tions between HPV infection and psychosocial stress. In
this large-scale case-control study, bereaved women (i.e.,
loss of a family member due to death) showed a 62% in-
creased risk of HR-HPV prevalence [25], but analyses
were not adjusted for potential HPV infection risk
factors. Thus, the independent effect of bereavement re-
mains unclear. In light of the substantially increased risk
of CIN grade 2 or worse diagnosis among women youn-
ger than 30 years with HR-HPV infections that persisted
at least 12 months [4], our findings may suggest that in
particular young women with chronic exposure to
stressful demands are susceptible to HPV-associated
CIN and cervical cancer. This assumption is strengthened
by previous studies that have demonstrated a link between
different kind of stressors, including life stressors [29, 31],
intimate partner violence [28], passive/helplessness reac-
tions to stress [27], parental death during childhood [26],
bereavement [25], and the long-term consequences of
persistent HR-HPV infections, i.e., cervical dysplasia and
cancer. Notably, the groups did not differ in chronic stress
levels at follow-up, which is most likely due to the reduc-
tion in the sample size (i.e., from N = 188 to n = 42).
Future studies with longer follow-up periods are needed
to verify the proposed role of chronic stress in HPV-
associated cervical carcinogenesis.
Regarding mechanisms underlying the link between
chronic stress and HR-HPV presence and persistence,
our study is the first to investigate different aspects of
diurnal cortisol secretion (i.e., CAR and AUCgday) as
potential mediators for the association between stress
and HR-HPV infection. As hypothesized, we found an
increased cortisol awakening response and total cortisol
output over the day in HR-HPV positive women com-
pared to HR-HPV negative women at baseline. Likewise,
at 12-months follow up, HR-HPV positive women also
showed a slightly increased cortisol awakening response
compared to HR-HPV negative women. Notably, the
groups did not differ in their total cortisol output, which,
again, is most likely due to the reduced sample size at
12-months follow up. Group differences were of medium
to large effect size and independent of potential HPV in-
fection risk factors. These findings provide first evidence
for HPA axis hyperactivity in HR-HPV positive women.
Considering the suppressive effects of increased cortisol
levels on cell-mediated immune responses [21] that are
important in HR-HPV clearance [6, 45] our results also
support the suggestion of an active role for cortisol in
the control of HR-HPV infection.
Interestingly, however, we were unable to confirm
either cortisol awakening response or total cortisol
output as mediators of the associations found between
chronic stress and HR-HPV presence. For explanation of
the missing mediation effect of cortisol awakening re-
sponse regarding the chronic stress-HR-HPV relation-
ship, we suggest three hypotheses. First, chronic stress
and the CAR/diurnal cortisol output were measured on
a different time scale (past 3 months vs. present day),
which may explain the lack of association. Further stud-
ies employing long-term measures of HPA axis function-
ing (e.g., hair cortisol) may be more likely to uncover
significant relationships. Second, the interaction between
chronic stress, endocrine, and immune mechanisms in
the field of HR-HPV infection might be too complex to
be adequately covered by linear statistical models.
Finally, it is possible that we were unable to detect a
mediation effect of cortisol on the chronic stress-HR-
HPV associations because our study was underpowered
to reveal small to medium effects.
Our results may have clinical implications in that they
suggest that stress management programs of young HR-
HPV positive women with HPV axis hyperactivity and
chronic exposure to stress could provide a psychobio-
logical benefit. If stress management programs are di-
rected at helping HR-HPV positive women to adaptively
cope with demands of daily life, daily cortisol secretion
and the course of HR-HPV infection might be positively
affected. For example, it has previously been demon-
strated that a stress management program using a
combination of educative and cognitive-behavioral skills
led to lower chronic stress and cortisol awakening
response in participants suffering from chronic stress
due to overwork [46].
The present study has several strengths, including the
prospective study design that allowed us to investigate
the role of chronic stress and cortisol in the course of
HR-HPV infection. Moreover, HR-HPV test results were
given to the participants after they had completed the
study questionnaires. This is important to exclude con-
founding effects of distress due to being tested HR-HPV
positive [47, 48] on the stress measures in our study.
Kuebler et al. BMC Cancer          (2021) 21:419 Page 8 of 10
Furthermore, we controlled for a variety of potential
HR-HPV risk factors to rule out confounding influence
on the investigated associations. The study also has
some limitations. It was an observational study, so that
causal interpretations of the observed associations
remain speculative. The generalizability of our findings
might be limited to young women. Furthermore, because
of the relatively small sample size and the follow-up
period restricted to 12months our data should be inter-
preted with caution until confirmed in larger studies
with longer follow-up periods. Additionally, only the
initially HR-HPV positive individuals were investigated
at follow-up. It is possible that women with a negative
HR-HPV status at baseline became infected at follow-up.
Moreover, condom use has not been assessed in this
study, and it cannot be ruled out that our cases with
persistent infections may, in fact, have been cases with
re-infections. Finally, the reduction of sample size for
cortisol assessment in the HR-HPV negative group due
to limited financial and organizational reasons must be
mentioned as limitation.
Conclusions
Taken together, we found first evidence that chronic
stress and a dysregulated diurnal cortisol secretion might
be independent risk factors for HR-HPV presence in
young women. Future research is needed to replicate
our findings in larger populations with longer follow-up
periods.
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